Bionano Genomics, Inc.
BNGO
$3.65
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.46M | 30.78M | 33.33M | 36.58M | 37.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.46M | 30.78M | 33.33M | 36.58M | 37.47M |
| Cost of Revenue | 27.97M | 30.40M | 33.93M | 25.98M | 27.15M |
| Gross Profit | 494.00K | 380.00K | -599.00K | 10.60M | 10.32M |
| SG&A Expenses | 30.91M | 41.61M | 59.69M | 75.12M | 90.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.27M | 96.80M | 126.65M | 143.20M | 167.53M |
| Operating Income | -47.81M | -66.03M | -93.32M | -106.62M | -130.06M |
| Income Before Tax | -83.64M | -111.98M | -135.79M | -204.09M | -226.77M |
| Income Tax Expenses | 58.00K | 33.00K | -4.00K | 11.00K | 18.00K |
| Earnings from Continuing Operations | -83.70 | -112.02 | -135.78 | -204.10 | -226.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -83.70M | -112.02M | -135.78M | -204.10M | -226.79M |
| EBIT | -47.81M | -66.03M | -93.32M | -106.62M | -130.06M |
| EBITDA | -34.36M | -52.00M | -78.10M | -93.40M | -116.53M |
| EPS Basic | -58.69 | -93.29 | -147.20 | -309.25 | -368.97 |
| Normalized Basic EPS | -23.42 | -41.90 | -84.16 | -111.90 | -147.67 |
| EPS Diluted | -58.69 | -93.29 | -147.20 | -309.25 | -368.97 |
| Normalized Diluted EPS | -23.42 | -41.90 | -84.16 | -111.90 | -147.67 |
| Average Basic Shares Outstanding | 6.90M | 5.08M | 4.10M | 3.25M | 2.65M |
| Average Diluted Shares Outstanding | 6.90M | 5.08M | 4.10M | 3.25M | 2.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |